home / stock / nrsn / nrsn short
Short Information | NeuroSense Therapeutics Ltd. (NASDAQ:NRSN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,333,974 |
Total Actual Volume | 10,799,378 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 116,699 |
Average Short Percentage | 20.87% |
Is there a NRSN Short Squeeze or Breakout about to happen?
See the NRSN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-19-2024 | $0.761 | $0.7316 | $0.7911 | $0.512 | 1,119,365 | 258,194 | 23.07% |
07-18-2024 | $0.77 | $0.7601 | $0.78762 | $0.7 | 318,891 | 67,871 | 21.28% |
07-17-2024 | $0.871 | $0.7877 | $0.871 | $0.73 | 670,022 | 146,490 | 21.86% |
07-16-2024 | $0.96 | $0.8785 | $0.96 | $0.7849 | 498,171 | 91,420 | 18.35% |
07-15-2024 | $1.01 | $0.9241 | $1.0299 | $0.89995 | 198,888 | 27,688 | 13.92% |
07-12-2024 | $1.03 | $1.01 | $1.05 | $0.8666 | 352,935 | 63,431 | 17.97% |
07-11-2024 | $0.97 | $1.03 | $1.1 | $0.97 | 249,977 | 43,020 | 17.21% |
07-10-2024 | $0.945 | $0.97 | $0.99 | $0.91 | 272,309 | 95,216 | 34.97% |
07-09-2024 | $1.21 | $0.9301 | $1.4 | $0.9067 | 881,166 | 197,309 | 22.39% |
07-08-2024 | $1.27 | $1.1499 | $1.27 | $1.1 | 392,065 | 57,472 | 14.66% |
07-05-2024 | $1.3 | $1.23 | $1.32 | $1.05 | 350,958 | 82,305 | 23.45% |
07-03-2024 | $1.34 | $1.32 | $1.4 | $1.24 | 466,319 | 159,947 | 34.3% |
07-02-2024 | $1.09 | $1.24 | $1.5 | $1.07 | 2,511,088 | 703,925 | 28.03% |
07-01-2024 | $1.06 | $1.08 | $1.13 | $0.98 | 1,436,197 | 58,150 | 4.05% |
06-28-2024 | $1.02 | $1.12 | $1.14 | $0.9589 | 509,956 | 143,412 | 28.12% |
06-27-2024 | $0.87 | $1.02 | $1.04 | $0.87 | 211,575 | 84,146 | 39.77% |
06-26-2024 | $0.8074 | $0.8516 | $0.8516 | $0.698 | 132,146 | 15,254 | 11.54% |
06-25-2024 | $0.84 | $0.846 | $0.85 | $0.8001 | 32,320 | 1,826 | 5.65% |
06-24-2024 | $0.841 | $0.845272 | $0.89 | $0.8 | 122,570 | 24,862 | 20.28% |
06-21-2024 | $0.91 | $0.898 | $0.94 | $0.821 | 72,460 | 12,036 | 16.61% |
News, Short Squeeze, Breakout and More Instantly...
NeuroSense Therapeutics Ltd. Company Name:
NRSN Stock Symbol:
NASDAQ Market:
NeuroSense Therapeutics Ltd. Website:
NeuroSense's PARADIGM ALS Clinical Trial Demonstrates Up to 73% Improved Complication-Free Survival Following Statistically Significant Slowing of Disease Progression PR Newswire NeuroSense to submit the 12-month data to FDA to discuss path forward CAMBRIDGE, Mass. ...
NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as a Disease Modifying Drug PR Newswire Disease progression was slowed by 36% (p=...
NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results PR Newswire Following positive 6-month clinical outcomes from phase 2b (PARADIGM) clinical trial, Company expects additional biomarker and 12-month clinical in the near term ...